Skip to main content

Some NLM-NCBI services and products are experiencing heavy traffic, which may affect performance and availability. We apologize for the inconvenience and appreciate your patience. For assistance, please contact our Help Desk at info@ncbi.nlm.nih.gov.

British Heart Journal logoLink to British Heart Journal
. 1985 Jul;54(1):86–90. doi: 10.1136/hrt.54.1.86

Intravenous sotalol for the treatment of atrial fibrillation and flutter after cardiopulmonary bypass. Comparison with disopyramide and digoxin in a randomised trial.

T J Campbell, T P Gavaghan, J J Morgan
PMCID: PMC481854  PMID: 3893488

Abstract

The efficacy of sotalol in treating acute atrial fibrillation and flutter after open heart surgery was compared with that of a digoxin/disopyramide combination. Forty adult patients with postoperative atrial arrhythmias were randomised into either group 1 (sotalol 1 mg/kg bolus intravenously plus 0.2 mg/kg intravenously over 12 hours) or group 2 (digoxin 0.75 mg intravenously, then two hours later disopyramide 2 mg/kg intravenous bolus and 0.4 mg/kg/h intravenously for 10 hours). In each group, 17 out of 20 patients reverted to sinus or junctional rhythm within 12 hours. The time to reversion in group 1 was significantly shorter than in group 2. Systolic blood pressure fell by greater than or equal to 20 mm Hg or to less than or equal to 90 mm Hg during drug administration in 17 out of 20 patients in group 1 (sotalol withdrawn in two) and in none out of 20 in group 2. Two patients in group 1 developed transient bradycardia (sotalol withdrawn in one). None of 17 patients in group 1 and two of 17 in group 2 relapsed temporarily into atrial fibrillation during the 12 hours of intravenous treatment. On continued oral treatment, one late relapse occurred in group 1 and five in group 2, and five patients in group 2 had disopyramide withdrawn because of anticholinergic side effects (acute urinary retention in four). Sotalol was as effective as the digoxin/disopyramide combination and acted significantly faster. Sensitivity to beta blockade in these patients may be related to high plasma catecholamine concentrations known to occur after cardiopulmonary bypass.

Full text

PDF
86

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Birkhead J. S., Vaughan Williams E. M. Dual effect of disopyramide on atrial and atrioventricular conduction and refractory periods. Br Heart J. 1977 Jun;39(6):657–660. doi: 10.1136/hrt.39.6.657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Campbell T. J., Morgan J. J. Treatment of atrial arrhythmias after cardiac surgery with intravenous disopyramide. Aust N Z J Med. 1980 Dec;10(6):644–649. doi: 10.1111/j.1445-5994.1980.tb04246.x. [DOI] [PubMed] [Google Scholar]
  3. Engelman R. M., Haag B., Lemeshow S., Angelo A., Rousou J. H. Mechanism of plasma catecholamine increases during coronary artery bypass and valve procedures. J Thorac Cardiovasc Surg. 1983 Oct;86(4):608–615. [PubMed] [Google Scholar]
  4. Frishman W. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 1. Pharmacodynamic and pharmacokinetic properties. Am Heart J. 1979 May;97(5):663–670. doi: 10.1016/0002-8703(79)90195-9. [DOI] [PubMed] [Google Scholar]
  5. Gavaghan T. P., Feneley M. P., Campbell T. J., Morgan J. J. Atrial tachyarrhythmias after cardiac surgery: results of disopyramide therapy. Aust N Z J Med. 1985 Feb;15(1):27–32. doi: 10.1111/j.1445-5994.1985.tb02726.x. [DOI] [PubMed] [Google Scholar]
  6. Johnson L. W., Dickstein R. A., Fruehan C. T., Kane P., Potts J. L., Smulyan H., Webb W. R., Eich R. H. Prophylactic digitalization for coronary artery bypass surgery. Circulation. 1976 May;53(5):819–822. doi: 10.1161/01.cir.53.5.819. [DOI] [PubMed] [Google Scholar]
  7. Latour Y., Dumont G., Brosseau A., LeLorier J. Effects of sotalol in twenty patients with cardiac arrhythmias. Int J Clin Pharmacol Biopharm. 1977 Jun;15(6):275–278. [PubMed] [Google Scholar]
  8. Neuvonen P. J., Elonen E., Tanskanen A., Tuomilehto J. Sotalol and prolonged Q-Tc interval. Lancet. 1981 Aug 22;2(8243):426–426. doi: 10.1016/s0140-6736(81)90876-x. [DOI] [PubMed] [Google Scholar]
  9. Rizos I., Senges J., Jauernig R., Lengfelder W., Czygan E., Brachmann J., Kübler W. Differential effects of sotalol and metoprolol on induction of paroxysmal supraventricular tachycardia. Am J Cardiol. 1984 Apr 1;53(8):1022–1027. doi: 10.1016/0002-9149(84)90630-1. [DOI] [PubMed] [Google Scholar]
  10. Senges J., Lengfelder W., Jauernig R., Czygan E., Brachmann J., Rizos I., Cobbe S., Kübler W. Electrophysiologic testing in assessment of therapy with sotalol for sustained ventricular tachycardia. Circulation. 1984 Mar;69(3):577–584. doi: 10.1161/01.cir.69.3.577. [DOI] [PubMed] [Google Scholar]
  11. Singh B. N., Vaughan Williams E. M. A third class of anti-arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474. Br J Pharmacol. 1970 Aug;39(4):675–687. doi: 10.1111/j.1476-5381.1970.tb09893.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Stephenson L. W., MacVaugh H., 3rd, Tomasello D. N., Josephson M. E. Propranolol for prevention of postoperative cardiac arrhythmias: a randomized study. Ann Thorac Surg. 1980 Feb;29(2):113–116. doi: 10.1016/s0003-4975(10)61647-5. [DOI] [PubMed] [Google Scholar]
  13. Touboul P., Atallah G., Kirkorian G., Lamaud M., Moleur P. Clinical electrophysiology of intravenous sotalol, a beta-blocking drug with class III antiarrhythmic properties. Am Heart J. 1984 May;107(5 Pt 1):888–895. doi: 10.1016/0002-8703(84)90823-8. [DOI] [PubMed] [Google Scholar]
  14. Weiner P., Bassan M. M., Jarchovsky J., Iusim S., Plavnick L. Clinical course of acute atrial fibrillation treated with rapid digitalization. Am Heart J. 1983 Feb;105(2):223–227. doi: 10.1016/0002-8703(83)90517-3. [DOI] [PubMed] [Google Scholar]
  15. Wichmann J., Ertl G., Höhne W., Schweisfurth H., Wernze H., Kochsiek K. Alpha-receptor restriction of coronary blood flow during atrial fibrillation. Am J Cardiol. 1983 Oct 1;52(7):887–892. doi: 10.1016/0002-9149(83)90435-6. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES